Fewer Deaths with Tighter Hematocrit Target in Polycythemia VeraDecember 10, 2012Leukemia, Myelodysplasia, TransplantationRare Diseases
ASH12: New Proteasome Inhibitor Shines In All-Oral Myeloma RegimenDecember 10, 2012Lymphoma & Plasma Cell Disorders
With Ponatinib, CML Resistance Is Squashed - For NowDecember 10, 2012Leukemia, Myelodysplasia, Transplantation
Studies put kibosh on statins for breast cancer preventionDecember 10, 2012Preventive CareBreast Cancer
Adjuvant Chemotherapy Boosts Survival in Locoregional Recurrent Breast CancerDecember 10, 2012Breast Cancer
Induction Anthracycline Skipped in Pediatric Leukemia RegimenDecember 10, 2012Leukemia, Myelodysplasia, TransplantationPediatrics
Experimental Ibrutinib Could Change Treatment of CLLDecember 10, 2012Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
HEM-ONC CHAT: Dr. James N. George, 'Keep At It'December 10, 2012Leukemia, Myelodysplasia, Transplantation
ASH12: Apixaban cuts risk of venous thromboembolismDecember 10, 2012Leukemia, Myelodysplasia, Transplantation
HEM-ONC CHAT: What Research Area is on Top of Your Agenda?December 10, 2012Leukemia, Myelodysplasia, Transplantation
ONC-CHAT: What Did You Learn this Week that Will Change the Way You Work?December 8, 2012Breast Cancer
San Antonio Roundtable, Part 4: Everolimus in Clinical Practice, a New CDK InhibitorDecember 7, 2012Breast Cancer
Late Leukemia Risk Rises after Breast Cancer TherapyDecember 7, 2012Breast CancerLeukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Genetic Vulnerabilities Identified in Residual TNBC After Neoadjuvant ChemoDecember 7, 2012Breast Cancer
